πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10543221

Beta-lactamase inhibitors, formulations, and uses thereof

The Regents of the University of California Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10543280

Stabilization of biomolecules using sugar polymers

The Regents of the University of California Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10543283

Intranasal administration of guanidinylated aminoglycosides

The Regents of the University of California Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10537528

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds

The Regents of the University of California Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10537529

Cell-free methods of producing vault particles and vault particles resulting therefrom

The Regents of the University of California Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10537535

Histone deacetylase inhibitors

The Regents of the University of California Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10533190

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10533056

Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics

The Regents of the University of California Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10526359

Thiosaccharide mucolytic agents

The Regents of the University of California Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10526619

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10517942

Polypeptide glycopeptide fragments from the V1/V2 and V3 domains of the HIV-1 envelope pro

The Regents of the University of California Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10518074

Compositions comprising nanostructures for cell, tissue and artificial organ growth, and m

The Regents of the University of California Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10517898

Compositions and methods related to hematologic recovery

The Regents of the University of California Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10519467

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10517491

Cardiac phase-resolved non-breath-hold 3-dimensional magnetic resonance angiography

The Regents of the University of California Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10520499

Methods of diagnosing and treating autism

The Regents of the University of California Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10513712

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10512630

Compositions and methods for treating cancer

The Regents of the University of California Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10512669

Blockade of inflammatory proteases with cyclic peptides

The Regents of the University of California Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10507239

V1/V2 fragments of a HIV-1 envelope glycoprotein

The Regents of the University of California Β· Granted Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10507284

Daily periodic target-zone modulation in the model predictive control problem for artifici

The Regents of the University of California Β· Granted Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10501816

Compositions and methods for detecting human pegivirus 2 (HPgV-2)

The Regents of the University of California Β· Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10500271

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

The Regents of the University of California Β· Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10500177

Glutarate compounds for treating ischemia-reperfusion injuries

The Regents of the University of California Β· Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted